HBS: Therapy Related Malignant Hematology & Oncology Emergencies, 11/22/17
All hospital-based specialties.
After participation in this CME activity, the learner will be able to:
- Discuss the side-effect profile of traditional chemotherapy.
- Recognize the side-effects of novel B-cell lymphoma therapies.
- Describe cultural implications to treating lung cancers and modern side-effects of lung cancer treatment.
- Anticipate the emergencies related to the emerging field of immunotherapy.
Planner: Jeanna Goo, MD MPH, Department of Hospital Medicine, HBS CME Coordinator, KPSF
Speaker: Raymond Liu, MD
Disclosure Statement: The faculty and planners for this activity, as well as the CME staff, do not have any relevant financial relationships with commercial interests or affiliations to disclose.
Accreditation Statement: The Kaiser San Francisco (San Francisco, CA 94115) is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
- 0.00 AAFP
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance